1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Next-generation CD40 agonists for cancer immunotherapy
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Rationale and clinical development of CD40 agonistic antibodies for cancer immunotherapy
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Smoking reduces the efficacy of belimumab in mucocutaneous lupus
(
- Contribution to journal › Article
-
Mark
Uptake of rheumatology biosimilars in the absence of forced switching
(
- Contribution to journal › Article
- 2016
-
Mark
Novel strategies for the treatment of grass pollen-induced allergic rhinitis
(
- Contribution to journal › Scientific review
- 2006
-
Mark
Antibody microarray-based oncoproteomics
(
- Contribution to journal › Article
- 2005
-
Mark
Inhibiting complement regulators in cancer immunotherapy with bispecific mAbs.
(
- Contribution to journal › Article
-
Mark
Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritis.
(
- Contribution to journal › Article